N-acetylglutamate Synthetase Deficiency
📧 Sign up to get email alerts when something new happens for N-acetylglutamate Synthetase Deficiency.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-08-26FDA Approved: CARBAGLU — Supplemental Application (Recordati Rare Diseases)
The FDA approved a supplemental application for CARBAGLU (carglumic acid) submitted by Recordati Rare Diseases.
-
FDA approval · 2010-03-18FDA Approved: CARBAGLU — Original Application (Recordati Rare Diseases)
CARBAGLU (carbaglumic acid) was approved by the FDA in an original application to treat hyperammonemia due to N-acetylglutamate synthetase d…